Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00795132 · ClinicalTrials.gov registry record · Phase 2
Hematopoietic Cell Transplantation for Pediatric Patients With Hematologic Malignancies
A Phase 2 study, sponsored by University of Utah.
- Completed
- Registry status
- Phase 2
- Development phase
- 47
- Enrollment target
NCT00795132 is a Phase 2 study that has completed, run by University of Utah. The registered enrollment target is 47 participants.
The verdict
NCT00795132, a Phase 2 study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 47 participants
- Enrollment target
Study Summary
This is a phase II trial of reduced intensity conditioning with Bu/Flu/ATG in pediatric patients with hematologic malignancies at high risk for transplant related mortality with standard transplantation. Patients qualify based on organ system dysfunction, active but stable infection, history of previous transplant or late stage disease. We plan to enroll 45 patients through the Pediatric Blood and Marrow Transplant Consortium (PBMTC) and anticipate that the outcome of the trial will pave the way for phase II or III disease specific protocols addressing efficacy of the approach compared to standard transplant approaches in better risk patients.
Interventions
- DRUG Fludarabine
- DRUG Busulfan
- DRUG Cyclosporine
- DRUG Mycophenolate mofetil
- DRUG Anti-Thymocyte Globulin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2004-04 |
| Est. Completion | 2009-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00795132
The ClinicalTrials.gov registry entry for NCT00795132 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Fludarabine is the first listed.
NCT00795132 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00795132 about?
NCT00795132 is a clinical study titled "Hematopoietic Cell Transplantation for Pediatric Patients With Hematologic Malignancies". This is a phase II trial of reduced intensity conditioning with Bu/Flu/ATG in pediatric patients with hematologic malignancies at high risk for transplant related mortality with standard transplantation. Patients qualify based on organ system dysfunction, active but stable infection, history of prev...
What is the current status of trial NCT00795132?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 47 participants. The study started on 2004-04. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00795132?
The interventions under investigation include: Fludarabine (DRUG), Busulfan (DRUG), Cyclosporine (DRUG), Mycophenolate mofetil (DRUG), Anti-Thymocyte Globulin (DRUG).
Who is sponsoring clinical trial NCT00795132?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.